|
1
|
Harb-de la Rosa A, Acker M, Kumar RA and
Manoharan M: Epigenetics application in the diagnosis and treatment
of bladder cancer. Can J Urol. 22:7947–7951. 2015.PubMed/NCBI
|
|
2
|
Bid HK: Words of wisdom. Re: Markers
predicting response to Bacillus Calmette-Guérin immunotherapy in
high-risk bladder cancer patients: a systematic review. Eur Urol.
61:846–847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ploeg M, Aben KKH and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ye F, Wang L, Castillo-Martin M, McBride
R, Galsky MD, Zhu J, Boffetta P, Zhang DY and Cordon-Cardo C:
Biomarkers for bladder cancer management: Present and future. Am J
Clin Exp Urol. 2:1–14. 2014.PubMed/NCBI
|
|
5
|
Jiang QQ, Liu B and Yuan T: MicroRNA-16
inhibits bladder cancer proliferation by targeting Cyclin D1. Asian
Pac J Cancer Prev. 14:4127–4130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu
X, Wu J, Zhu Y, Zheng X, et al: MicroRNA-124-3p inhibits cell
migration and invasion in bladder cancer cells by targeting ROCK1.
J Transl Med. 11:2762013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang M, Zhuang Q and Cui L: MiR-194
inhibits cell proliferation and invasion via repression of RAP2B in
bladder cancer. Biomed Pharmacother. 80:268–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ichimi T, Enokida H, Okuno Y, Kunimoto R,
Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama
K, et al: Identification of novel microRNA targets based on
microRNA signatures in bladder cancer. Int J Cancer. 125:345–352.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shin SS, Park SS, Hwang B, Kim WT, Choi
YH, Kim WJ and Moon SK: MicroRNA-106a suppresses proliferation,
migration, and invasion of bladder cancer cells by modulating MAPK
signaling, cell cycle regulators, and Ets-1-mediated MMP-2
expression. Oncol Rep. 36:2421–2429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo J, Cao R, Yu X, Xiao Z and Chen Z:
MicroRNA-223-3p inhibits human bladder cancer cell migration and
invasion. Tumour Biol. 39:10104283176916782017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu H, Duan P, Zhu H and Rao D: miR-613
inhibits bladder cancer proliferation and migration through
targeting SphK1. Am J Transl Res. 9:1213–1221. 2017.PubMed/NCBI
|
|
12
|
Egawa H, Jingushi K, Hirono T, Ueda Y,
Kitae K, Nakata W, Fujita K, Uemura M, Nonomura N and Tsujikawa K:
The miR-130 family promotes cell migration and invasion in bladder
cancer through FAK and Akt phosphorylation by regulating PTEN. Sci
Rep. 6:205742016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng Y, Zhang X and Li P, Yang C, Tang J,
Deng X, Yang X, Tao J, Lu Q and Li P: MiR-200c promotes bladder
cancer cell migration and invasion by directly targeting RECK.
OncoTargets Ther. 9:5091–5099. 2016. View Article : Google Scholar
|
|
14
|
Feng C, Sun P, Hu J, Feng H, Li M, Liu G,
Pan Y, Feng Y, Xu Y, Feng K, et al: miRNA-556-3p promotes human
bladder cancer proliferation, migration and invasion by negatively
regulating DAB2IP expression. Int J Oncol. 50:2101–2112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stanier P, Abu-Hayyeh S, Murdoch JN,
Eddleston J and Copp AJ: Paralogous sm22alpha (Tagln) genes map to
mouse chromosomes 1 and 9: Further evidence for a paralogous
relationship. Genomics. 51:144–147. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nohata N, Sone Y, Hanazawa T, Fuse M,
Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa
M, et al: miR-1 as a tumor suppressive microRNA targeting TAGLN2 in
head and neck squamous cell carcinoma. Oncotarget. 2:29–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao G, Xia C, Yang J, Liu J, Du H, Kang
X, Lin Y, Guan R, Yan P and Tang S: miR-133b regulates the
expression of the Actin protein TAGLN2 during oocyte growth and
maturation: A potential target for infertility therapy. PLoS One.
9:e1007512014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma
M and Liu JF: The tumor-suppressive function of miR-1 by targeting
LASP1 and TAGLN2 in esophageal squamous cell carcinoma. J
Gastroenterol Hepatol. 31:384–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nair VS, Maeda LS and Ioannidis JPA:
Clinical outcome prediction by microRNAs in human cancer: A
systematic review. J Natl Cancer Inst. 104:528–540. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Wu X, Wang B, Wang Q and Han L:
Mechanisms of miR-145 regulating invasion and metastasis of ovarian
carcinoma. Am J Transl Res. 9:3443–3451. 2017.PubMed/NCBI
|
|
24
|
Salem SM, Hamed AR and Mosaad RM: MTDH and
MAP3K1 are direct targets of apoptosis-regulating miRNAs in
colorectal carcinoma. Biomed Pharmacother. 94:767–773. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen GM, Zheng AJ, Cai J, Han P, Ji HB and
Wang LL: microRNA-145-3p inhibits non-small cell lung cancer cell
migration and invasion by targeting PDK1 via the mTOR signaling
pathway. J Cell Biochem. 119:885–895. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujii T, Shimada K, Tatsumi Y, Hatakeyama
K, Obayashi C, Fujimoto K and Konishi N: microRNA-145 promotes
differentiation in human urothelial carcinoma through
downregulation of syndecan-1. BMC Cancer. 15:8182015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blick C, Ramachandran A, McCormick R,
Wigfield S, Cranston D, Catto J and Harris AL: Identification of a
hypoxia-regulated miRNA signature in bladder cancer and a role for
miR-145 in hypoxia-dependent apoptosis. Br J Cancer. 113:634–644.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kou B, Gao Y, Du C, Shi Q, Xu S, Wang CQ,
Wang X, He D and Guo P: miR-145 inhibits invasion of bladder cancer
cells by targeting PAK1. Urol Oncol. 32:846–854. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dvorakova M, Nenutil R and Bouchal P:
Transgelins, cytoskeletal proteins implicated in different aspects
of cancer development. Expert Rev Proteomics. 11:149–165. 2014.
View Article : Google Scholar : PubMed/NCBI
|
